BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25446129)

  • 1. Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
    Wang J; Hansen K; Edwards R; Van Houten B; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):7-12. PubMed ID: 25446129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial division inhibitor-1 induces mitochondrial hyperfusion and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Akita M; Suzuki-Karasaki M; Fujiwara K; Nakagawa C; Soma M; Yoshida Y; Ochiai T; Tokuhashi Y; Suzuki-Karasaki Y
    Int J Oncol; 2014 Nov; 45(5):1901-12. PubMed ID: 25174275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization.
    Suzuki-Karasaki Y; Fujiwara K; Saito K; Suzuki-Karasaki M; Ochiai T; Soma M
    Oncotarget; 2015 Aug; 6(25):21572-88. PubMed ID: 26057632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10A and fibroblast cells but affects Bcl-2 antagonist-induced respiratory changes.
    Clerc P; Ge SX; Hwang H; Waddell J; Roelofs BA; Karbowski M; Sesaki H; Polster BM
    Br J Pharmacol; 2014 Apr; 171(8):1988-99. PubMed ID: 24206264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy for targeted killing of tumor cells: Induction of multipolar acentrosomal mitotic spindles with a quinazolinone derivative mdivi-1.
    Wang J; Li J; Santana-Santos L; Shuda M; Sobol RW; Van Houten B; Qian W
    Mol Oncol; 2015 Feb; 9(2):488-502. PubMed ID: 25458053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
    Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
    Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis.
    Tanaka A; Youle RJ
    Mol Cell; 2008 Feb; 29(4):409-10. PubMed ID: 18313377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and Bak.
    Qian W; Salamoun J; Wang J; Roginskaya V; Van Houten B; Wipf P
    Bioorg Med Chem Lett; 2015 Feb; 25(4):856-63. PubMed ID: 25582599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative--Enhancement of both extrinsic and intrinsic apoptosis pathways.
    Berger A; Quast SA; Plötz M; Hein M; Kunz M; Langer P; Eberle J
    Biochem Pharmacol; 2011 Jan; 81(1):71-81. PubMed ID: 20858462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis.
    Holloway J; Seeley A; Cobbe N; Turkington RC; Longley DB; Evergren E
    Cell Death Dis; 2024 Jan; 15(1):40. PubMed ID: 38216558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.
    Lee CS; Jang ER; Kim YJ; Myung SC; Kim W; Lee MW
    Invest New Drugs; 2012 Apr; 30(2):548-57. PubMed ID: 21120579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells.
    Ke S; Zhou T; Yang P; Wang Y; Zhang P; Chen K; Ren L; Ye S
    Int J Nanomedicine; 2017; 12():2531-2551. PubMed ID: 28408823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells.
    Han J; Goldstein LA; Gastman BR; Rabinovitz A; Wang GQ; Fang B; Rabinowich H
    Leukemia; 2004 Oct; 18(10):1671-80. PubMed ID: 15356645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.